ArticleVirology journal2025
Genetic diversity of sarbecoviruses isolated from microbats in Southern Japan.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A self-assembled nanoparticle vaccine displaying chimeric and trimeric RBD-HRC elicits broad-spectrum neutralizing antibodies against multiple coronaviruses.Microbiology spectrum · 2026Article
- Experimental evolution of Rc-o319 sarbecovirus spike protein reveals limited ACE2 adaptability.Virus evolution · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundBat-derived sarbecoviruses, members of the Betacoronavirus genus, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pose a zoonotic threat. While sarbecoviruses have been isolated from bats in eastern Japan, their distribution and diversity in southern Japan remain poorly understood. We investigated the genetic characteristics and zoonotic potential of bat-derived sarbecoviruses from Rhinolophus cornutus in the Kagoshima and Kumamoto Prefectures, Japan.
methodsWe collected 133 oral swab samples from R. cornutus between 2022 and 2025. The samples were inoculated into various Vero cell derivatives to isolate sarbecoviruses. The virus genomes were sequenced and subjected to phylogenetic analyses. Viral replication was assessed in vitro. Cross-species potential was evaluated in vivo through experimental infection in Syrian hamsters.
resultsSix and three sarbecoviruses from the Kagoshima and Kumamoto Prefectures, respectively, were isolated. Genetic analyses revealed substantial diversity among our isolates (95.98–99.95% nucleotide identity). Phylogenetic analyses revealed clustering of the isolates separately from those found in eastern Japan, indicating regional genetic divergence among bat populations. Our isolates exhibited deletions in the receptor-binding domain of the spike protein. These deletions attenuate the viral binding affinity to human angiotensin-converting enzyme 2 (ACE2) receptors. This suggests a limited capacity of our isolates to bind human ACE2. Our isolates exclusively replicated in Vero cells expressing R. cornutus-derived ACE2 (RcACE2). Syrian hamsters, a model for SARS-CoV-2 infection, were not susceptible to infection from our isolates, suggesting limited potential for cross-species transmission.
conclusionsWe characterized genetically diverse sarbecoviruses circulating in R. cornutus populations in southern Japan. Although the isolates appear to have a low immediate zoonotic risk, they likely represent only a small fraction of the sarbecoviruses circulating among bats. Given the potential presence of viruses with greater zoonotic capacity, continuous surveillance is critical for early detection of emerging threats and advancing our understanding of coronavirus ecology in bat populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.